Form 4: ClearPoint Neuro Director Timothy Richards Acquires Shares in Lieu of Fees

Director Timothy Richards acquired 2,069 shares of ClearPoint Neuro common stock on July 1, 2024, in lieu of fees under the company's Non-Employee Director Compensation Plan.

Summary

• On July 1, 2024, Timothy T. Richards, a director of ClearPoint Neuro, Inc. acquired 2,069 shares of common stock.
• The acquisition was made under the company's Fifth Amended and Restated 2013 Incentive Compensation Plan.
• These shares were issued in payment of fees owed to Richards under the Non-Employee Director Compensation Plan, as amended and restated.
• The price per share was $5.39, based on the closing price of ClearPoint Neuro's common stock on June 28, 2024.
• Following the transaction, Richards beneficially owns 63,630 shares of ClearPoint Neuro common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. The director accepting stock in lieu of cash is a mildly positive signal.

Positives

• A director taking shares in lieu of cash compensation demonstrates confidence in the company's future.

Industry Context

This transaction is a routine disclosure related to insider activity. It reflects a director's compensation in the form of company stock, which is a common practice.

Comparison to Industry Standards

• Director compensation in the form of stock is a common practice across the industry to align the interests of directors with those of shareholders.
• The specific amount and terms of the stock compensation would need to be compared to peer companies to assess whether it is in line with industry standards.
• Companies like Medtronic, Boston Scientific, and Stryker also utilize stock-based compensation for their directors.

Related Party Transactions

• The issuance of shares to Timothy Richards, a director, under the Non-Employee Director Compensation Plan constitutes a related party transaction.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates